Yuwei Wang, Ph.D.
Affiliations: | 2011 | Pharmaceutics and Pharmaceutical Chemistry | University of Utah, Salt Lake City, UT |
Area:
PharmacyGoogle:
"Yuwei Wang"Parents
Sign in to add mentor| David W. Grainger | grad student | 2011 | University of Utah | |
| (Local delivery of small interfering RNA to inhibit osteoporosis using a combination device strategy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang Y, Grainger DW. (2019) Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments. Advanced Drug Delivery Reviews |
| Wang Y, Liu J, Zhang J, et al. (2014) A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs. International Journal of Medical Sciences. 11: 479-87 |
| Ying W, Liu J, Tsang KY, et al. (2014) Abstract 4578: A novel polymer-anticancer drug micelle formulation showing enhanced efficacy over Abraxane Cancer Research. 74: 4578-4578 |
| Wang Y, Grainger DW. (2014) Barriers to advancing nanotechnology to better improve and translate nanomedicines Frontiers of Chemical Science and Engineering. 8: 265-275 |
| Wang Y, Grainger DW. (2013) Developing siRNA therapies to address osteoporosis. Therapeutic Delivery. 4: 1239-46 |
| Wang Y, Tran KK, Shen H, et al. (2012) Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials. Biomaterials. 33: 8540-7 |
| Yang D, Liu X, Jiang X, et al. (2012) Effect of molecular weight of PGG-paclitaxel conjugates on in vitro and in vivo efficacy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 124-31 |
| Wang Y, Grainger DW. (2012) RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Advanced Drug Delivery Reviews. 64: 1341-57 |
| Wang Y, Panasiuk A, Grainger DW. (2011) Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures. Molecular Pharmaceutics. 8: 1016-24 |
| Takahashi H, Wang Y, Grainger DW. (2010) Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 147: 400-7 |